Emitasvir Phosphate Capsules (Dongwei’En/Dongyangguang) – 100?mg

$2.00

Dongwei’En Emitasvir Phosphate Capsules contain 100?mg per capsule and come in 28-count boxes (4 blisters of 7). Manufactured by Yichang Dongyangguang Changjiang Pharma Co., Ltd., and approved under NMPA H20200015. This NS5A inhibitor is used in hepatitis C virus (HCV) research, especially in combination with Sofosbuvir, to study viral replication, resistance, and antiviral synergy.

Compare

描述

Emitasvir Phosphate is an NS5A inhibitor that disrupts the HCV replication complex. The Dongyangguang formulation must be used alongside Sofosbuvir for genotype?1, non?cirrhotic chronic HCV research models . Not intended as monotherapy. While clinically used, these capsules are offered for laboratory and preclinical research in virology, biochemical assays, and pharmacology.

Contents hide

1 Product Specifications

2 Mechanism of Action

3 Research Applications

4 Safety & Handling

5 Core Keywords

6 Research Use Disclaimer

Product Specifications

Parameter	Details
Product Name	Emitasvir Phosphate Capsules (Dongwei’En)
Generic Name	Emitasvir Phosphate
Dosage Form	Oral capsule
Strength	100?mg per capsule
Pack Size	28 capsules (0.1?g × 28)
Approval Number	H20200015 (NMPA China)
Manufacturer	Yichang Dongyangguang Changjiang Pharma Co., Ltd.
Storage Conditions	Store ??30?°C, sealed
Intended Use	Laboratory research: HCV NS5A inhibition, antiviral synergy, resistance studies

Mechanism of Action

Emitasvir Phosphate targets the HCV NS5A protein, blocking viral replication by disrupting the formation of the replication complex. Used in tandem with Sofosbuvir, it enhances antiviral efficacy against genotype 1 HCV

Research Applications

Genotype 1 HCV replication and inhibition assays
Antiviral combination therapy studies (e.g., with Sofosbuvir)
Resistance profiling against NS5A inhibitors
Pharmacokinetic and pharmacodynamics research in hepatic cells

Safety & Handling

For research use only—not for clinical or veterinary use
Handle with PPE in lab environments
Store as directed and discard if capsules degrade

Core Keywords

Emitasvir Phosphate capsules, DongweiEn NS5A inhibitor, HCV genotype 1 research drug, NMPA H20200015, sofosbuvir combination study, hepatitis C antiviral capsules

Research Use Disclaimer

This product is strictly for laboratory and preclinical research use. It is not approved for diagnostic, clinical, therapeutic, or veterinary use. Misuse may result in health or regulatory consequences. Use only under qualified protocols and institutional guidance.

其他信息

重量	1 公斤
尺寸	26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Emitasvir Phosphate Capsules (Dongwei’En/Dongyangguang) – 100?mg” 的评价者